Patents by Inventor Jane Marie Paul

Jane Marie Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6346618
    Abstract: A process for the asymmetric transformation of a racemic compound of formula (I) wherein R1 is H or a alkyl group having up to 20 carbon atoms, R2 is H, or an alkyl, aryl, alkaryl or aralkyl group having up to 20 carbon atoms, and X is H, a halogen atom, tert-butyl, or any other removable substituent, comprises reaction of racemic compound (I) with an enantiomerically-enriched acid HY*, wherein Y* is a chiral group, to form a diastereomeric salt of compound (I) having Y* as a counterion. The salt obtained can then be reduced to give enantiomerically-enriched galanthamine, or a derivative thereof.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: February 12, 2002
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: David Andrew Chaplin, Nicholas Bernard Johnson, Gerard Andrew Potter, Jane Marie Paul
  • Patent number: 6274758
    Abstract: A process for the preparation of an enantioenriched sulfone of formula (1), which comprises asymmetric hydrogenation of vinyl sulfone of formula (2) wherein R1 and R2 are each independently a hydrocarbon group of less than 20 carbons atoms, optionally substituted at any position, or either of R1 and R3 is H, and X is a coordinating group, in the presence of a stereoselective chiral catalyst.
    Type: Grant
    Filed: September 24, 1998
    Date of Patent: August 14, 2001
    Assignee: Darwin Discovery, Ltd.
    Inventors: Jane Marie Paul, Christopher Palmer
  • Patent number: 6031124
    Abstract: The subject invention pertains to compounds of the formula Y.sup.1 Y.sup.2 N--(CH.sub.2).sub.4 --CH.dbd.C(Ph)--X wherein Y.sup.1 and Y.sup.2 are independently H or a removable blocking group, or Y.sup.1 and Y.sup.2 together are a removable divalent blocking group; and X is COOCH.sub.3 or a group convertible thereto. Such a compound may be cyclised, by Michael addition, to give methylphenidate, if necessary after removing blocking group(s) and converting X to COOCH.sub.3. The subject invention also pertains to methods for preparing compounds of the invention.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: February 29, 2000
    Assignee: Medeva Europe Limited
    Inventors: Martin Edward Fox, Jane Marie Paul
  • Patent number: 6018043
    Abstract: The subject invention concerns a process for preparing a compound of formula (3) ##STR1## in enantio-enriched form, comprising reducing a compound of formula (4) ##STR2## using an asymmetric enantiospecific reductant, wherein A.sup.1 .dbd.A.sup.2 .dbd.H or A.sup.1, A.sup.2 .dbd.O; B.sup.1 .dbd.B.sup.2 .dbd.H or B.sup.1, B.sup.2 .dbd.O; Z.dbd.H, C.sub.1-20 alkyl or a precursor thereof, or a removable protecting group for nitrogen, e.g, acyl or alkyloxycarbonyl; Y.dbd.H or a substituent; R.sup.1 .dbd.C.sub.1-20 alkyl; and R is an optional, additional substituent.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: January 25, 2000
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Ulrich Conrad Dyer, Jane Marie Paul, Raymond McCague
  • Patent number: 6002045
    Abstract: A process for racemising an optically-enriched chiral amine of the formula: R.sup.1 --CH(NR.sup.3 R.sup.4)--R.sup.2, wherein R.sup.1 is aromatic or unsaturated alkyl; R.sup.2 is aromatic or alkyl; and R.sup.3 and R.sup.4 are independently selected from hydrogen, alkyl and aryl; and wherein any combination(s) of two of the R groups may form a ring; comprises treatment of the optically-enriched amine with a metal hydroxide in an aprotic polar solvent.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: December 14, 1999
    Assignee: Chirotech Technology Limited
    Inventors: Jane Marie Paul, Gerard Andrew Potter